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In this issue, Overholtzer et al. (2007) describe a new nonapoptotic cell death pathway 
termed “entosis” in mammary epithelial cells that have detached from the extracellular 
matrix (ECM). Given that surviving detachment from the ECM is an event associated with 
the progression of epithelial cancers, entosis—along with apoptosis—may contribute to 
tumor suppression by promoting the elimination of cancer cells.Apoptosis is important to sculpt 
tissues and eliminate unnecessary 
cells as well as for tumor suppres-
sion. However, mammalian devel-
opment is surprisingly intact in mice 
deficient in the essential proapop-
totic regulators Bax and Bak (Lind-
sten et al., 2000). Thus, in the 
absence of apoptosis, many types 
of developmental cell death can still 
occur by other mechanisms. For 
example, different pathways to cell 
death are involved in lumen forma-
tion in glandular epithelia. Indeed, 
cells with defective apoptosis can 
be diverted to necrotic cell death, 
but the roles of necrosis and per-
haps other modes of cell elimina-
tion in cancer and development are 
poorly understood. Reporting in 
this issue, Brugge and colleagues 
(Overholtzer et al., 2007) describe 
a new mode of nonapoptotic cell 
elimination called “entosis” that 
resembles cell cannibalism and the 
cell-in-cell phenotype observed in 840 Cell 131, November 30, 2007 ©2007some tumors. Their work provides 
yet another example of the fact that 
cell death is not just about apopto-
sis anymore.
In mammary epithelia, clearing of 
the lumen, which occurs for the pur-
pose of secretion, is a normal devel-
opmental process in puberty. Clear-
ing occurs when luminal cells that 
have detached from the ECM undergo 
a specialized form of apoptotic cell 
death termed anoikis. During anoikis, 
cells detach from the ECM and lose 
survival signaling through integrins 
(Gilmore, 2005). Luminal clearing has 
been studied in great detail because 
three-dimensional mammary epithe-
lial duct morphogenesis in the pres-
ence of an ECM can be modeled 
in vitro (Nelson and Bissell, 2006). 
Detachment from the ECM, or meta-
bolic or oxidative stress, triggers elim-
ination of these central acinar cells 
through caspase-dependent apop-
tosis or necrotic cell death if apop-
tosis is defective (Figure 1) (Debnath  Elsevier Inc.et al., 2002; Karantza-Wadsworth 
et al., 2007; Mailleux et al., 2007). In 
mammary acini, it is the acinar center 
where metabolic stress initiates the 
catabolic process of autophagy that 
sustains cell survival, which when 
inhibited can either accelerate apop-
tosis or induce necrotic cell death of 
apoptosis-defective cells (Figure 1) 
(Karantza-Wadsworth et al., 2007). 
Unregulated cell proliferation and 
decreased apoptosis in epithelial 
cancers such as those of breast are 
typified by filling of the lumen with 
cells. Therefore, identifying and char-
acterizing the various mechanisms 
for cell elimination in glandular epi-
thelia and establishing whether these 
events are deregulated in cancers, or 
can be reactivated therapeutically, is 
of great importance.
Upon examination of mammary 
epithelial cell lines in suspension, 
Overholtzer et al. noticed the pres-
ence of cells within other cells. Fur-
ther investigation of this phenom-
figure 1. Regulation of cell Death in Mammary Acinar cells
Three-dimensional mammary ductal morphogenesis modeled in vitro leads to multicellular spher-
oid acinar formation in the presence of an extracellular matrix (ECM). Cells at the external rim of 
the acinus form tight and adherens junctions (TJ and AJ, respectively) and establish a polarized 
epithelial layer surrounded by a basement membrane, an organizational state that maintains sur-
vival signaling in these cells (Nelson and Bissell, 2006). The central acinar cells are subjected to 
stresses and are eliminated by several different mechanisms, generating a hollow lumen. The 
stress of cell detachment and the loss of survival signaling by integrins activate a form of cell 
death by apoptosis termed anoikis, resulting in lumen formation (Debnath et al., 2002; Nelson 
and Bissell, 2006). The central acinar cells are also subjected to metabolic stress induced by hy-
poxia and likely also nutrient deprivation that initiates the catabolic cellular self-eating process of 
autophagy to recycle intracellular nutrients to support survival (Karantza-Wadsworth et al., 2007). 
Autophagy can enable long-term survival of apoptosis-defective central acinar cells facilitating 
luminal filling. Inhibiting autophagy (and thereby nutrient recycling) in metabolically stressed, 
apoptosis-defective central acinar cells results in necrotic cell death (Karantza-Wadsworth et al., 
2007). ECM detachment of central acinar cells and adherens junction formation can also lead to 
cell invasion and lysosome-mediated degradation and cell death of the invading cell by the pro-
cess of entosis (Overholtzer et al., 2007). The failure to eliminate luminal cells can be one factor 
that contributes to filling of the lumen, which is a step in the progression of epithelial cancers.enon revealed that detachment of 
mammary epithelial cells from the 
ECM initiates a new pathway of non-
apoptotic cell death called entosis in 
which one cell invades into another. 
This process requires the formation 
of adherens junctions in the absence 
of integrin signaling and force-driven 
invasion of one cell into another cell. 
Cell invasion in entosis requires the 
Rho GTPase and its downstream 
effector ROCK in the internalizing 
cells and appears to result from the 
absence of integrin-ECM attachment and generation of an unopposed and 
unbalanced contractile force. Entosis 
is thus not a phagocytic process but 
requires force generation from the 
actin/myosin cytoskeleton. Remark-
ably, viability of the internalized cells 
is sustained in the short term, and 
a fraction of the internalized cells 
can either extricate themselves or 
are expelled from the host cell. The 
predominant fate of the internal-
ized cells is, however, lysosome-
mediated degradation and non-
apoptotic cell death. Surprisingly, Cell 131, Novelysosome-mediated degradation of 
internalized cells does not appear to 
use the autophagy pathway, which 
degrades large cellular constituents 
such as organelles and internalized 
pathogens by sequestering them in 
vesicles and targeting them to lyso-
somes for degradation. Thus, how 
the invading, internalized cells are 
delivered to or recognized by lyso-
somes is not known, nor are the sig-
nals in the internalized cells that initi-
ate the degradation process.
A key question is whether ento-
sis is another mechanism to elimi-
nate cells that detach from the ECM 
in vivo. This cell absorption through 
entosis may contribute to the elimina-
tion of ductal epithelial cells in normal 
development or may be a mecha-
nism of tumor suppression. Tumors 
with cytological features of cell can-
nibalization resembling entosis have 
been reported, but the mechanism 
and significance is unknown (Abodief 
et al., 2006). To address the poten-
tial occurrence of entosis in cancer, 
Overholtzer and colleagues examined 
pleural fluid exudates from individu-
als with breast cancer. Tumor cells 
in these pleural fluid samples are in 
suspension and lack ECM attach-
ment. Indeed, cells within cells typical 
of entosis were observed to varying 
degrees and could also be detected 
in primary tumors. Now the chal-
lenge is to establish the functional 
significance of entosis. The authors 
observed an increase in cell colony 
formation by mammary cell lines in 
suspension in the presence of Rho 
and ROCK inhibitors that block ento-
sis, consistent with a role for entosis 
in cell elimination.
It is unclear if entosis is merely a 
means for cell elimination or if can-
nibalism of the invading cell provides 
an advantage to the host cell, per-
haps through nutrient recycling dur-
ing metabolic stress. If entosis were 
a mechanism of eliminating detached 
cancer cells, then stimulating it would 
be therapeutically advantageous and 
inhibiting it (with Rho or ROCK inhibi-
tors, for example) would be detri-
mental. Epithelial tumor progression 
is associated with the epithelial-to-
mesenchymal transition. Thus, it will mber 30, 2007 ©2007 Elsevier Inc. 841
be interesting to determine whether 
the transition to a mesenchymal fate 
provides an advantage to cancer 
cells enabling them to escape ento-
sis, or whether entosis is deregulated 
in cancers. As with the initial descrip-
tion of a new phenomenon, which 
often raises more questions than it 
provides answers, defining the pro-
cess of entosis and the genes that 
control it will be needed to establish 
its relevance in vivo.842 Cell 131, November 30, 2007 ©2007
Hematopoietic stem cells (HSCs) 
were once believed to avoid the 
ravages of age by residing in bone 
marrow, where they generate cells 
of nearly all hematopoietic lineages. 
Yet, HSCs are also present in blood 
and other tissues. Studies that mea-
sure the numbers of HSCs in blood 
reveal that nearly all HSCs in the 
bone marrow periodically enter the 
cell cycle (Cheshier et al., 1999; 
Wright et al., 2001). In this issue, 
Massberg, von Andrian, and their 
colleagues chart new patrol routes 
for HSCs, deduce how their migra-
tion is controlled, and establish a 
raison d’être outside of the bone 
marrow (Massberg et al., 2007).
There is recent support for the 
long-held view that HSCs reside in 
association with osteoblasts near 
trabecular bone—the tissue in the 
inner cavities of bones (Adams 
stem cells on
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and Scadden, 2006). This niche is 
thought to represent a nurturing 
environment, providing signals for 
HSC survival, relative quiescence, 
and self renewal (Figure 1). How-
ever, methods for identifying HSCs 
have progressively improved, and 
we now know that larger numbers of 
HSCs can be found in the more cen-
trally located perivascular regions 
of bones (Kiel et al., 2005). Although 
the bone marrow is still considered 
to be the principal site for blood cell 
formation, spleen and liver are also 
important sites for this process dur-
ing fetal development. Moreover, 
blood cell formation in these tis-
sues can be transiently reactivated 
(termed extramedullary hematopoi-
esis) under conditions of unusual 
demand for blood cells such as dur-
ing a parasitic infection or during 
myelofibrosis.
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issue.Although mobilization of HSCs for 
therapeutic transplantation is being 
extensively studied (Winkler and 
Levesque, 2006), mechanisms associ-
ated with normal egress into the circu-
lation are poorly understood. It is likely 
that cell adhesion molecules, proadhe-
sive chemokines, crowding, neutrophil-
derived proteases, and innervation of 
niches by the sympathetic nervous sys-
tem all determine whether HSCs remain 
sessile or are induced to migrate. The 
blood of a mouse contains between 
100 and 400 HSCs at any one time, 
but they reside there for only seconds, 
and some eventually return to the bone 
marrow (Wright et al., 2001). Thus, there 
may be continual low-level exchange of 
HSCs between hematopoietic niches 
in different bones. Many studies sug-
gest that export of stem and progenitor 
cells from bone marrow can increase 
dramatically during infection.
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